Skip to content
Research/Supplements/Magnesium Threonate

Magnesium Threonate

Brain-penetrating magnesium for sleep and cognition. Supplement.

Intelligence Profile

Clinical Applications

Clinical research on magnesium threonate (specifically magnesium-L-threonate) remains limited, with only a handful of completed studies and several ongoing or planned trials examining its therapeutic potential.

Cognitive and Neurological Applications

The primary clinical focus has been on cognitive enhancement and early-stage Alzheimer's disease. Two completed Phase 2 trials (NCT03531684 and NCT03601169) investigated magnesium-L-threonate in early Alzheimer's disease patients and older adults, examining both efficacy/safety and dosage comparisons. However, specific results from these trials are not available in the current evidence base.

Preclinical research suggests magnesium-L-threonate may have neurophysiological benefits, though one comparative study (PMID: 42084749) found that magnesium-acetyl-taurate demonstrated superior bioavailability and effects on synaptic plasticity compared to magnesium-L-threonate in laboratory models.

Urological Applications

Emerging research indicates potential therapeutic value for bladder dysfunction. One study (PMID: 41985648) demonstrated that magnesium-L-threonate supplementation normalized magnesium deficiency and alleviated bladder overactivity in a cyclophosphamide-induced cystitis model, apparently through anti-inflammatory mechanisms and barrier restoration.

Athletic Performance and Recovery

Current clinical trials are investigating magnesium-L-threonate for sports medicine applications. Two active studies (NCT07015047 and NCT07640685) are examining its effects on sleep quality, recovery, and athletic performance in collegiate athletes, though results are not yet available.

Stress and Sleep Management

One completed trial (NCT06889584) evaluated a supplement combination including magnesium threonate for stress and sleep outcomes, but specific findings are not detailed in the available evidence.

Clinical Evidence Limitations: The clinical evidence base for magnesium threonate remains thin, with most trials recently completed or still ongoing. Published results from human studies are not readily available, making it difficult to draw definitive conclusions about clinical efficacy for any indication. More robust clinical data is needed to establish therapeutic applications and optimal dosing protocols.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before starting any new supplement regimen.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.